Samuhaer Azhati

Dr. Samuhaer Azhati

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
SLShuning Liu
Shuning Liu
WYWenqian Yao
Wenqian Yao
YWYan Wei
Yan Wei
SASamuhaer Azhati
Samuhaer Azhati
YWYutong Wu
Yutong Wu
CLChang Liu
Chang Liu
Background: Astaxanthin is a lipid-soluble carotenoid with antioxidant and anti-inflammatory properties, but its effects on exercise performance and post-exercise recovery remain uncertain. This systematic review and meta-analysis aimed to evaluate the effects of astaxanthin supplementation on exercise performance and recovery-related biomarkers in healthy participants and athletes. Methods: This review followed PRISMA 2020 guidelines. PubMed, Web of Science, Embase, EBSCO, the Cochrane Library, and CNKI were searched from inception to January 2026. Randomized controlled trials comparing oral astaxanthin supplementation with placebo or control were included. Performance outcomes included VO2max, time-trial or endurance-related performance, and maximal workload or power output. Recovery-related outcomes included creatine kinase, lactate dehydrogenase, malondialdehyde, interleukin-6, and related biomarkers. Standardized mean differences with 95% confidence intervals were pooled. Results: Twenty-four RCTs were included. Astaxanthin significantly reduced creatine kinase levels (SMD = −0.45, 95% CI: −0.83 to −0.07). Lactate dehydrogenase also favored astaxanthin (SMD = −0.93, 95% CI: −1.39 to −0.48), although heterogeneity was substantial. No significant effects were observed for malondialdehyde or interleukin-6. Astaxanthin did not significantly improve VO2max, time-trial performance, or maximal workload/power output. Conclusions: Current evidence suggests that astaxanthin may be more beneficial for post-exercise recovery than for direct performance enhancement. The most consistent effect was observed for creatine kinase, whereas the LDH finding should be interpreted cautiously. Further well-powered trials with standardized dosing, duration, exercise protocols, and outcome assessments are needed.

20 August 2025 in Genes
Verified
Journal Article
Open access
PDF file
LCLun Chen
Lun Chen
MWMingrui Wang
Mingrui Wang
LLLongtianjiao Liu
Longtianjiao Liu
XJXiaoyu Jiang
Xiaoyu Jiang
ZCZihang Cao
Zihang Cao
LSLijun Shi
Lijun Shi
Background/Objectives: Previous multi-ethnic genome-wide association studies (GWAS) have identified the GALNT13 rs10196189 polymorphism as a potential genetic marker linked to sprint–power performance. However, its relevance in East Asian populations, particularly the Han Chinese, remains untested. This study aimed to replicate the association of rs10196189 with elite sprint–power athlete status in Han Chinese males and examine its potential influence on physical performance traits and tissue-specific gene regulation. Methods: A total of 188 healthy Han Chinese males (49 elite sprint–power athletes and 139 non-athletic controls) were genotyped using the TaqMan assay. Assessments included strength, sprint, jump, anaerobic power, DXA-derived body composition, and muscle ultrasound. Logistic regression and ROC analyses evaluated the predictive value of rs10196189. Linear regression models adjusted for age and BMI tested genotype–phenotype associations. Tissue expression and functional networks were analyzed using GTEx and HumanBase databases. Results: The G allele frequency was significantly higher in athletes (12.2%) than in controls (5.4%, p = 0.042). Dominant and additive models effectively predicted athlete status (OR = 2.53–2.58, p < 0.05). Although most traits showed no significant associations post-correction, medial gastrocnemius thickness showed a nominal association (β = 0.371, p = 0.011). Functional analyses revealed high GALNT13 expression in brain tissue and co-expression networks enriched in synaptic signaling and glycosylation pathways. Conclusions: This is the first study to validate the association of GALNT13 rs10196189 with elite athletic status in Han Chinese males. Findings provide novel population-specific evidence and propose tissue-specific glycosylation and neural mechanisms as pathways linking this variant to sprint–power phenotypes.

11 July 2025 in Genes
Verified
Journal Article
Open access
PDF file
MWMingrui Wang
Mingrui Wang
SASamuhaer Azhati
Samuhaer Azhati
HCHangyu Chen
Hangyu Chen
YZYanyan Zhang
Yanyan Zhang
LSLijun Shi
Lijun Shi
Background/Objectives: Cardiac aging involves the progressive structural and functional decline of the myocardium. Endurance training is a well-recognized non-pharmacological intervention that counteracts this decline, yet the molecular mechanisms driving exercise-induced cardiac rejuvenation remain inadequately elucidated. This study aimed to identify key effector genes and regulatory pathways by integrating human cardiac aging transcriptomic data with multi-omic exercise response datasets. Methods: A systems biology framework was developed to integrate age-downregulated genes (n = 243) from the GTEx human heart dataset and endurance-exercise-responsive genes (n = 634) from the MoTrPAC mouse dataset. Thirty-seven overlapping genes were identified and subjected to Enrichr for pathway enrichment, KEA3 for kinase analysis, and ChEA3 for transcription factor prediction. Candidate effector genes were ranked using ToppGene and ToppNet, with integrated prioritization via the FLAMES linear scoring algorithm. Results: Pathway enrichment revealed complementary patterns: aging-associated genes were enriched in mitochondrial dysfunction and sarcomere disassembly, while exercise-responsive genes were linked to protein synthesis and lipid metabolism. TTN, PDK family kinases, and EGFR emerged as major upstream regulators. NKX2-5, MYOG, and YBX3 were identified as shared transcription factors. SMPX ranked highest in integrated scoring, showing both functional relevance and network centrality, implying a pivotal role in mechano-metabolic coupling and cardiac stress adaptation. Conclusions: By integrating cardiac aging and exercise-responsive transcriptomes, 37 effector genes were identified as molecular bridges between aging decline and exercise-induced rejuvenation. Aging involved mitochondrial and sarcomeric deterioration, while exercise promoted metabolic and structural remodeling. SMPX ranked highest for its roles in mechano-metabolic coupling and redox balance, with X-inactivation escape suggesting sex-specific relevance. Other top genes (e.g., KLHL31, MYPN, RYR2) form a regulatory network supporting exercise-mediated cardiac protection, offering targets for future validation and therapy.

3 July 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
MWMingrui Wang
Mingrui Wang
SASamuhaer Azhati
Samuhaer Azhati
HCHangu Chen
Hangu Chen
YZYanyan Zhang
Yanyan Zhang
LSLijun Shi
Lijun Shi
Background/Objectives: Cardiac aging involves progressive structural and functional decline of the myocardium. Endurance training is a well-recognized non-pharmacological intervention that counteracts this decline, yet the molecular mechanisms driving exercise-induced cardiac rejuvenation remain inadequately elucidated. This study aimed to identify key effector genes and regulatory pathways by integrating human cardiac aging transcriptomic data with multi-omic exercise response datasets. Methods: A systems biology framework was developed to integrate age-downregulated genes (n = 243) from the GTEx human heart dataset and endurance exercise–responsive genes (n = 634) from the MoTrPAC mouse dataset. Thirty-seven overlapping genes were identified and subjected to Enrichr for pathway enrichment, KEA3 for kinase analysis, and ChEA3 for transcription factor prediction. Candidate effector genes were ranked using ToppGene and ToppNet, with integrated prioritization via the FLAMES linear scoring algorithm. Results: Pathway enrichment revealed complementary patterns: aging-associated genes were enriched in mitochondrial dysfunction and sarcomere disassembly, while exercise-responsive genes were linked to protein synthesis and lipid metabolism. TTN, PDK family kinases, and EGFR emerged as major upstream regulators. NKX2-5, MYOG, and YBX3 were identified as shared transcription factors. SMPX ranked highest in integrated scoring, showing both functional relevance and network centrality, implying a pivotal role in mechano-metabolic coupling and cardiac stress adaptation. Conclusions: This integrative analysis identified SMPX as a top effector gene mediating the anti-aging effects of endurance exercise on the heart. These findings enhance mechanistic understanding of exercise-induced cardiac remodeling and provide a foundation for developing exercise-mimetic therapies.

12 June 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
SASamuhaer Azhati
Samuhaer Azhati
SLShuning Liu
Shuning Liu
RSRuizhe Song
Ruizhe Song
MLMingchen Li
Mingchen Li
YWYan Wei
Yan Wei
HZHuaichuan Zhang
Huaichuan Zhang
Background: Low back pain (LBP) is a major cause of disability in later life. We aimed to assess the population-level burden, demographic and epidemiological drivers, GBD-defined risk attribution, and future trajectory of LBP among Chinese adults aged 45 years and older. Methods: Using population-level estimates from the Global Burden of Disease Study 2023 (GBD 2023), we analyzed incidence, prevalence, and years lived with disability (YLDs) among Chinese adults aged 45 years and older from 1990 to 2023. We assessed temporal trends, decomposed changes in burden, evaluated age–period–cohort patterns, quantified YLDs attributable to three GBD-defined risk factors—high body mass index, occupational ergonomic factors, and smoking—and projected burden to 2040 using Bayesian age–period–cohort models. Results: In 2023, population-level GBD estimates indicated that LBP accounted for 30.29 million incident cases, 71.54 million prevalent cases, and 7.90 million YLDs among Chinese adults aged 45 years and older. Compared with 1990, these numbers increased by 101.54%, 97.08%, and 96.11%, respectively, despite declining age-restricted age-standardized incidence, prevalence, and YLD rates. Expansion of the population aged 45 years and older was the main driver of the increasing absolute burden, whereas favorable epidemiological change offset part of this increase. High body-mass index showed the largest increase in attributable burden and was the only risk factor with rising age-standardized attributable YLD rates. Model-based projections suggested that age-restricted age-standardized burden would continue to decline through 2040. Conclusions: LBP remains a growing absolute burden among middle-aged and older adults in China despite declining age-restricted age-standardized rates. Future disability reduction will require integrated strategies combining risk-factor control, rehabilitation, functional support, and age-sensitive care.

19 April 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
YWYan Wei
Yan Wei
SLShuning Liu
Shuning Liu
TYTing You
Ting You
YLYu Xing Liu
Yu Xing Liu
WZWen Zhong
Wen Zhong
CLChang Liu
Chang Liu
Objective: Seaweed and microalgae provide antioxidants, polyunsaturated fatty acids, and bioactive compounds that may enhance exercise performance and accelerate recovery. However, evidence remains inconsistent. This systematic review and meta-analysis aimed to evaluate the effects of algae-derived supplementation on exercise performance and physiological recovery outcomes in healthy and athletic adults. Methods: This review was registered in PROSPERO (CRD420251166723) and conducted in accordance with PRISMA 2020 guidelines. PubMed, Web of Science, Embase, Cochrane Library, EBSCO, and CNKI were systematically searched for randomized controlled trials (RCTs) evaluating algae supplementation in exercise contexts. Inclusion and exclusion criteria were defined based on the PICOS framework. Primary outcomes included VO2max, Time to exhaustion (TTE), maximal power output (WRmax), Time-Trial (TT) performance, and creatine kinase (CK). Standardized mean differences (SMDs) with 95% confidence intervals (CIs) were calculated using a random-effects model. Subgroup, sensitivity, and publication bias analyses were performed. Results: Twenty-two RCTs (n = 822) investigating Spirulina, Chlorella, brown-algal polysaccharides, or astaxanthin met inclusion criteria. Algae supplementation showed a suggestive improvement in VO2max (SMD = 0.88, 95% CI: 0.00–1.75) and significantly improved in TTE (SMD = 1.06, 95% CI: 0.16–1.96), with smaller effects on WRmax (SMD = 0.29, 95% CI: 0.03–0.55), and no significant benefit for TT performance (SMD = −0.27, 95% CI: −0.74 to 0.21). Regarding recovery, CK concentrations were significantly reduced (SMD = −0.78, 95% CI: −1.28 to −0.28). Subgroup analysis suggested greater effects for Chlorella supplementation, higher dosages, and aerobic training contexts; reductions in muscle-damage markers were more evident following resistance exercise. Sensitivity analyses supported the robustness of the main findings with minimal evidence of publication bias. Conclusions: Algae-derived supplements—particularly Spirulina and Chlorella—may modestly enhance aerobic exercise performance and attenuate exercise-induced muscle damage under certain conditions. Effects appear to depend on algae species, dosing strategies, intervention duration, and training modality. High-quality, multi-center RCTs incorporating mechanistic endpoints are needed to clarify optimal application and to develop athlete-specific recommendations.